How to better consider and understand interindividual variability in response to polyphenols in clinical trials
2024

Understanding How People Respond Differently to Polyphenols in Diet

publication Evidence: moderate

Author Information

Author(s): Christine Morand

Primary Institution: Université Clermont Auvergne, INRAE, UNH, Clermont-Ferrand, France

Hypothesis

How can we better understand the differences in individual responses to polyphenols in clinical trials?

Conclusion

The study emphasizes the importance of recognizing individual variability in responses to polyphenols to improve clinical trial outcomes.

Supporting Evidence

  • Polyphenols have beneficial effects on cardiometabolic health, but clinical trials show mixed results.
  • Interindividual variability in response to polyphenols can be attributed to factors like genetics, age, and gut microbiota.
  • Data-driven methods and experimental designs can help address variability in clinical trials.

Takeaway

Some people react differently to the same foods, especially those with polyphenols, which are found in plants. This study looks at why that happens and how to study it better.

Methodology

The study reviews existing literature and proposes strategies for addressing variability in clinical trials involving polyphenols.

Potential Biases

Potential biases may arise from the reliance on existing data and the variability in study designs across different trials.

Limitations

The findings are based on post-hoc analyses and existing studies, which may not fully capture the complexity of individual responses.

Participant Demographics

The study discusses variability across different populations but does not provide specific demographic details.

Digital Object Identifier (DOI)

10.3389/fnut.2024.1522516

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication